n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Disease Models, Animal in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiser, B | 1 |
| Markwardt, F | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Disease Models, Animal
| Article | Year |
|---|---|
Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor.
Topics: Animals; Antithrombins; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Female | 1986 |